Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
PAFMJ-Pakistan Armed Forces Medical Journal. 2015; 65 (6): 803-808
en Inglés | IMEMR | ID: emr-173364

RESUMEN

Objective: To determine the frequency and association of depressive symptoms during pregnancy among wives of deployed Military soldiers


Study Design: Cross-sectional study


Place and Duration of Study: Combined Military Hospital Kharian from Oct 2013 to Dec 2013


Material and Methods: The sample population comprised of pregnant ladies who were wives of deployed military soldiers reporting for ante natal checkup at Combined Military Hospital Kharian. Beck Depression Inventory [BDI] was used to record the presence and severity of depressive symptoms. Age, gestation, parity, planned or unplanned pregnancy, education, level of family income, tobacco smoking, Family history of depression, Infertility treatments, previous pregnancy loss or complications, partner support and history of abuse or trauma were associated with depressive symptoms


Results: Out of 188, 41.5% had no depressive symptoms, 25.5% had mild, 20.2% had moderate and 12.8% had severe depressive symptoms. Advancing age, family history of psychiatric Illness, partner abuse, low family income and education, lack of partner support, smoking, increasing parity and gestation age are all significantly related to presence of depressive symptoms


Conclusion: This study showed a high frequency of depressive symptoms among wives of military soldiers during pregnancy. Special attention should be paid in elderly, multiparous and less educated ladies. Partner should avoid abuse and provide good support especially as the pregnancy advances. Declaration of interest: No conflict of interest for any author

2.
Medical Channel. 2001; 7 (4): 31-4
en Inglés | IMEMR | ID: emr-57606

RESUMEN

We have recently concluded a nation wide post marketing study on efficacy and safety of Moxonidine in mild to moderate hypertensives. In all 97 patients were enrolled and out of these 87 completed a 12 weeks trial. There was an average drop of 12.9 mmHg in the DBP and 16.5 mmHg in SBP. 80% patient required a daily dose of 0.2 - 0.4 mg of Moxonidine for control of their BP In 84% of the patients completing the trial the BP changed from moderate to mild or normal or from mild toonormal. The drug was well tolerated, only 2.3% having adverse effects. We conclude that the drug studied is an effective alternate for the control of hypertension


Asunto(s)
Humanos , Masculino , Femenino , Antihipertensivos/farmacología , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA